In a bioinformatics study by Ma et al. [84], it was shown that the high expression of APOBEC3G was also significantly associated with short overall survival (OS) in non-M3 acute myeloid leukemia (non-AML) patients, who are the vast majority of AML patients. The gene discussed is APOBEC3G; the disease is acute myeloid leukemia.